Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.7B | 4.4B | 5.2B | 4.7B |
| Cost of revenue | 1.8B | 2.0B | 1.9B | 1.9B |
| Gross profit | 2.9B | 2.4B | 3.3B | 2.9B |
| Operating expense | ||||
| Research & development | 145.1M | 283.1M | 150.8M | 223.0M |
| Selling general and admin | 1.1B | 1.1B | 1.1B | 1.0B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.7B | 1.0B | 2.1B | 1.6B |
| Non operating interest income | ||||
| Income | 23.2M | 30.1M | 26.4M | 22.8M |
| Expense | 140.8M | 139.3M | 141.5M | 138.7M |
| Other income expense | — | — | — | — |
| Pretax income | 1.7B | 1.5B | 1.9B | 1.7B |
| Tax provision | 307.0M | 361.8M | 332.9M | 329.4M |
| Net income | 1.4B | 1.1B | 1.6B | 1.3B |
| Basic EPS | 5.5 | — | 6.0 | 5.1 |
| Diluted EPS | 5.4 | — | 6.0 | 5.1 |
| Basic average shares | 262.4M | — | 261.7M | 261.6M |
| Diluted average shares | 263.9M | — | 263.0M | 263.2M |
| EBITDA | 2.2B | 2.0B | 2.4B | 2.1B |
| Net income from continuing op. | 1.7B | 1.5B | 1.9B | 1.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |